Regeneron will continue forth with its €220 million plans to revamp a former Dell plant in Ireland now that an interest group has pulled its appeal, making room to flesh out its product line beyond blazing eye treatment Eylea.
written on 28.03.2014
Regeneron clears roadblock for new plant in Irish tax haven
